ARTICLE | Company News
Oncovir, Quest Pharma deal
February 3, 2014 8:00 AM UTC
Quest and Oncovir partnered to evaluate Quest's oregovomab in combination with Oncovir's Hiltonol ( Poly-ICLC) adjuvant in an Italian Phase II trial in 20 patients with ovarian cancer, which is expec...